Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #110388 on Innovation Pharmaceuticals Inc (IPIX)
MinnieM
07/07/15 10:19 AM
#110389 RE: Rdunn88 #110388
BEVERLY, MA–(Marketwired – June 08, 2015) - Cellceutix Corporation (OTC: CTIX) (the “Company”), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, today provided shareholders an update on the status of the Company’s application to uplist to the NASDAQ exchange. Cellceutix last week learned that the application remains pending due to the price of CTIX stock currently below the minimum requirement.